By Tanya Lewis, Staff Writer
Published: 01/02/2014 08:29 AM EST on LiveScience
A 40-year-old man with a sore throat and fever was diagnosed with tonsillitis, and was prescribed penicillin, a common antibiotic. But several days later, the man developed a rash over his armpits, groin and buttocks — an unusual condition known as "baboon syndrome."
The condition, more formally called symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), is known as baboon syndrome because the rash on the patient's buttocks resembles the red hindquarters of some monkeys.
Because doctors often prescribe penicillin antibiotics to treat tonsillitis and other bacterial infections, it is important to be aware that baboon syndrome is one of the medication's possible side effects, wrote the researchers who reported the man's case online Nov. 28 in the journal BMJ Case Reports.
The condition is usually caused by an allergic reaction to penicillin drugs, but can also be caused by exposure to mercury or nickel, said Dr. Andreas Bircher, a dermatologist at University Hospital of Basel in Switzerland. (He was not involved in the study but has reported other cases of baboon syndrome.)
In the present case, during the man's initial examination, he had enlarged and inflamed tonsils, according to the physicians at the NHS Lothian hospital in the United Kingdom who reported the case. His regular doctor had prescribed penicillin for him two days earlier, but the patient became unable to swallow. [8 Strange Signs You're Having an Allergic Reaction]
The emergency-department doctor who saw the man started him on a course of intravenous benzylpenicillin (a different type than the oral penicillin) four times a day and gave him a single dose of intravenous dexamethasone, a steroid medication used to treat inflammation.
By the next day, the patient had developed a rash over his groins and inner elbow. Assuming it was a reaction to the penicillin, the doctor changed his antibiotic to clarithromycin (which is in a different class of antibiotics).
On the third day after being seen at the hospital, the patient's throat was much better, and he was able to swallow liquids and soft foods, but his rash had spread and become painful. At that point, the rash covered his armpits, buttocks, lower abdomen and upper thighs, and his groin showed signs of necrosis (dead tissue).
The doctors had to determine whether the patient was having a severe drug reaction, which would get better on its own, or a dangerous infection of flesh-eating bacteria (necrotizing fasciitis), which would require immediate removal of the dead or infected tissue.
The team started the patient on non-penicillin broad-spectrum antibiotics, which act against a range of bacteria, and took a tissue sample from his right groin. The sample tested negative for flesh-eating bacteria, so the patient was diagnosed with baboon syndrome.
"It's not a very common condition," Bircher told LiveScience. For unknown reasons, it's more prevalent in males, and usually seen in postpubescent people.
The patient stopped taking antibiotics, and used oral and topical steroids to treat his rash. He was discharged from the hospital 11 days after being admitted, and the rash disappeared.
"It's a true allergy," Bircher said. With steroid treatment, the rash usually fades within a week, but re-exposure to the drug or allergen can cause a relapse within one to two days, Bircher said.
Baboon syndrome typically appears a few hours to two days after a person takes an antibiotic. The syndrome rarely affects small children, but cases have been reported in an 18-month-old and a 5-year-old, the researchers noted in their case report. Recovery can sometimes take up to three weeks.
Exposure to penicillin, nickel or mercury are the most common causes of the syndrome, but it has also been linked to certain heartburn drugs, biological agents and chemotherapy.
Follow Tanya Lewis on Twitter and Google+. Follow us @livescience, Facebook & Google+. Original article on LiveScience.
Copyright 2014 LiveScience, a TechMediaNetwork company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. ]]>
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.